Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01723423 · ClinicalTrials.gov registry record

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

A clinical trial of Breast Cancer, sponsored by University of Michigan.

Completed
Registry status
4,436
Enrollment target
11
Study locations

NCT01723423 is a study of Breast Cancer that has completed, run by University of Michigan. The registered enrollment target is 4,436 participants, above the 2,800-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (58% higher). The trial reports 11 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01723423, a study of Breast Cancer, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
4,436 participants
Enrollment target
11
Study locations

Study Summary

The MROC Study seeks to evaluate and compare from the patient's point of view the leading options for breast reconstruction after mastectomy. This study will help patients, physicians, payers and policy makers better understand the various surgeries available for breast reconstruction. Although many women choose reconstruction, the number of options as well as their pros and cons can make decision making difficult and stressful. From this research, we hope to learn more about what works best for patients undergoing these operations.

Conditions Studied

Breast Cancer

Study Locations (11)

Michigan

  • University of Michigan Medical Center - Ann Arbor
  • St. Joseph's Mercy Health System - Ann Arbor

District of Columbia

  • Georgetown University Hospital - Washington D.C.

Georgia

  • Georgia Institute for Plastic Surgery - Savannah

Illinois

  • Northwestern Memorial Hospital - Chicago

Massachusetts

  • Brigham and Women's Hospital - Boston

New York

  • Memorial Sloan-Kettering Cancer Center - New York

Ohio

  • Ohio State University Medical Center - Columbus

Texas

  • M.D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 4,436 participants
Start Date 2011-08
Est. Completion 2016-12

Sponsor

University of Michigan

1,327 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01723423

The ClinicalTrials.gov registry entry for NCT01723423 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,436 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,800-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (58% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT01723423 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Michigan, District of Columbia, Georgia.

Frequently Asked Questions

What is clinical trial NCT01723423 about?

NCT01723423 is a clinical study titled "Mastectomy Reconstruction Outcomes Consortium (MROC) Study". The MROC Study seeks to evaluate and compare from the patient's point of view the leading options for breast reconstruction after mastectomy. This study will help patients, physicians, payers and policy makers better understand the various surgeries available for breast reconstruction. Although many...

What is the current status of trial NCT01723423?

This trial is currently completed. The enrollment target is 4,436 participants. The study started on 2011-08. Estimated completion is 2016-12.

What conditions does trial NCT01723423 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT01723423?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01723423 being conducted?

This trial has 11 study locations across District of Columbia, Georgia, Illinois, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.